News & Events
-
December 17, 2018
CPTR Newsletter – December 2018
CPTR Newsletter – December 2018 In this issue: In the Spotlight: TB-ReFLECT Manuscript Published Updates to the TB-PACTS Clinical Trial Data Repository Project Highlights: Application of the HFS-TB to Inform Regimen Development Programs Collaboration to Expand ReSeqTB Clinical Data Sets Supporting Global Surveillance of TB Resistance Progress with Regulatory Authorities LAM Biomarker Notes...... -
April 26, 2018
CPTR Newsletter – April 2018
CPTR Newsletter – April 2018 In this issue: ReSeqTB to be Adopted for WHO Surveillance of Drug-Resistant TB New Collaborations Expand TB-PACTS Database and Leverage Data for Analyses CPTR Workgroup Works to Advance Regulatory Qualification of LAM, a Promising New Biomarker TB-PBPK Model Progresses Toward EMA and FDA Qualification TB-ReFLECT Update: A Collaborative Effort...... -
February 5, 2018
Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed
Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Workshop (CPTR) 2018 Annual workshop originally scheduled for April 23-25, 2018. This workshop will be rescheduled later in 2018 to better align with deliverables from our programmatic efforts and alleviate some of the logistical challenges...... -
March 24, 2017
For Two Arizona-Based Nonprofits, Past Meets Present on World TB Day
On March 24, the world will recognize the 35th annual observance of World Tuberculosis (TB) Day. The leading cause of death by an infectious disease, TB kills 1.8 million people per year, according to the World Health Organization (WHO). Even more worrying is the increase in the number of strains of the bacteria Mycobacterium tuberculosis...... -
August 17, 2015
New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis
New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis The achievements and ongoing efforts of C-Path’s Critical Path to TB Drug Regimens (CPTR) initiative’s work on the Hollow Fiber System Model for Tuberculosis (HFS-TB) are detailed in a new supplement published in the Clinical Infectious Diseases journal. The supplement includes......